Also, MRZ is more dependent on caspase 8 than BTZ in myeloma and leukemia8, 16 and MRZ induces death in BTZ-resistant myeloma cells15, demonstrating that these inhibitors can trigger different death pathways. Here, CASC3 is linked to plasma cell myeloma.